Latest National Heart, Lung, and Blood Institute Stories
The Pulmonary Hypertension Association (PHA) approaches its 25th Anniversary in 2016 as the nation’s leader in funding scientific research investigating ways to prevent and cure pulmonary hypertension
Company’s cardiac imaging analysis software chosen to evaluate the efficacy of an NIH clinical research study using bone marrow stem cell injections during cardiac surgery to treat heart muscle
BHI to Provide Qualified EIRs to NHLBI and NINDS ROCKVILLE, Md. and BALTIMORE, Feb.
PCORI Commits Up To $25 Million to Fund Trials to Reduce Disparities in Hypertension Outcomes WASHINGTON, Dec.
Data Demonstrate Hydroxyurea Therapy Offers Safe, Effective Disease Management CINCINNATI, Nov.
Trial will evaluate if a daily dose of the statin, pitavastatin, can reduce the elevated risk of cardiovascular disease in this patient population MONTGOMERY, Ala., Oct.
NuvOx Pharma has been awarded a Phase I Small Business Innovative Research contract (contract # HHSN268201400045C) for “Development of Molecular Imaging Agents and Methods to Detect High Risk
RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., April 28, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc.
Albert Einstein College of Medicine is One of Four U.S. Field Sites for Landmark Study BRONX, N.Y., Feb. 24, 2014 /PRNewswire-USNewswire/ -- One in every six people in the U.S.
First findings released by National Institutes of Health (NIH) in largest and most comprehensive study ever conducted on Hispanic health. Washington, DC (PRWEB)
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.